Status | Study |
RECRUITING |
Study Name: Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (ARTEMIDE-Biliary01) Condition: Biliary Tract Cancer Date: 2023-10-26 Interventions: Rilvegostomig IV (intravenous) Q3W |
RECRUITING |
Study Name: Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs) Condition: Biliary Tract Cancer Date: 2023-03-06 Interventions: Participants will receive 1500 mg every 3 weeks, or every 4 weeks (in combination with chemotherapy every 3 weeks, or every 2 weeks, respectively) fro |
RECRUITING |
Study Name: A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) Condition: Biliary Tract Cancer Date: 2022-08-15 Interventions: IV infusion on day 1 and 14 of every 28 day cycle |
Recruiting |
Study Name: Apatinib as Second Line Therapy in Patients With Advanced Refractory Biliary Tract Cancers Condition: Biliary Tract Cancer Date: 2017-05-05 Interventions: Drug: Apatinib Apatinib 500mg, po, qd, every 4 weeks. |
Not yet recruiting |
Study Name: Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer Condition: Advanced or Metastatic Biliary Tract Cancer Date: 2017-04-21 Interventions: Drug: Varlitinib everyday |
Not yet recruiting |
Study Name: Pembrolizumab, a Monoclonal Antibody Against PD-1, in Combination With Capecitabine and Oxaliplatin (CAPOX) in People With Advanced Biliary Tract Carcinoma (BTC) Condition: Biliary Tract Cancer Date: 2017-04-12 Interventions: Drug: Pembrolizumab (MK-3475) |
Not yet recruiting |
Study Name: FOLFIRI as Salvage Treatment in Metastatic Biliary Tract Cancer (BTC) Patients Who Were Failed After Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study Condition: Biliary Tract Cancer Date: 2017-04-07 Interventions: Drug: Fluorouracil 5FU 400mg/m |
Not yet recruiting |
Study Name: Pemetrexed in Combination With Erlotinib as a Salvage Treatment in Patients With Metastatic Biliary Tract Cancer (BTC) Who Failed Gemcitabine Containing Chemotherapy: A Phase II Single Arm Prospective Study Condition: Biliary Tract Cancer Date: 2017-04-07 Interventions: Drug: Pemetrexed 500 MG Pemetr |
Not yet recruiting |
Study Name: Study of Nivolumab in Combination With Gemcitabine/Cisplatin or Ipilimumab for Patients With Advanced Unresectable Biliary Tract Cancer Condition: Biliary Tract Neoplasms Date: 2017-03-30 Interventions: Drug: Gemcitabine Gemcitabine |
Not yet recruiting |
Study Name: Varlitinib in Combination With Capecitabine for Advanced or Metastatic Biliary Tract Cancer Condition: Biliary Tract Cancer Date: 2017-03-16 Interventions: Drug: Varlitinib Varlitinib:30 |